Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1509.00 -7.15 (-0.47%) | NSE 1509.90 -7.10 (-0.47%) | Trade | Add

BSE Live

Jan 16, 16:01

1509.00 -7.15 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

106,864

10-Day

72,442

30-Day

31,122

495,166

Prev. Close

1516.15
Open Price

1516.15

Bid Price (Qty.)
1509.00 (9)
Offer Price (Qty.)
1535.00 (52)

NSE Live

Jan 16, 15:55

1509.90 -7.10 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

369,719

10-Day

351,864

30-Day

251,949

107,415

Prev. Close

1517.00
Open Price

1512.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ipca Laboratories (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.04	24.99	25.09	25.00	25.00
Total Share Capital	25.04	24.99	25.09	25.00	25.00
Reserves and Surplus	839.84	606.30	564.11	448.75	345.50
Total Reserves and Surplus	839.84	606.30	564.11	448.75	345.50
Total Shareholders Funds	864.88	631.29	589.20	473.75	370.50
Minority Interest	0.00	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	219.85	240.65	300.46	215.69	173.65
Deferred Tax Liabilities [Net]	82.84	68.16	59.01	53.07	48.95
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	302.69	308.81	359.47	268.76	222.60
CURRENT LIABILITIES
Short Term Borrowings	234.16	218.76	52.04	22.85	22.89
Trade Payables	120.05	94.16	94.19	90.17	76.04
Other Current Liabilities	65.49	102.56	43.42	33.14	31.73
Short Term Provisions	154.09	111.49	122.11	89.18	13.09
Total Current Liabilities	573.79	526.97	311.76	235.34	143.75
Total Capital And Liabilities	1,741.37	1,467.10	1,260.47	977.89	736.85
ASSETS
NON-CURRENT ASSETS
Tangible Assets	631.94	571.43	411.10	372.28	341.70
Intangible Assets	5.91	5.33	3.24	3.11	3.03
Capital Work-In-Progress	38.28	14.44	127.61	57.00	29.72
Fixed Assets	676.13	591.20	541.95	432.39	374.45
Non-Current Investments	32.54	41.17	9.53	8.64	3.60
Deferred Tax Assets [Net]	3.54	3.05	1.65	1.88	1.06
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	712.21	635.42	553.13	442.91	379.11
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	380.23	306.16	267.59	236.25	187.15
Trade Receivables	388.02	339.14	267.59	180.72	137.72
Cash And Cash Equivalents	10.79	11.32	9.41	10.12	5.48
Short Term Loans And Advances	213.15	174.68	162.75	107.89	27.39
OtherCurrentAssets	36.39	0.00	0.00	0.00	0.00
Total Current Assets	1,028.58	831.30	707.34	534.98	357.74
Total Assets	1,741.37	1,467.10	1,260.47	977.89	736.85
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	191.11	105.64	57.13	109.92	83.87
BONUS DETAILS
Bonus Equity Share Capital	20.90	20.90	20.90	20.90	20.90
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	30.44	28.45	0.01	3.55	3.60
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00